| 1 |
26312888 | Antagonism of aminoacid transport in primary CD4 T cells by HIV-1 Vpu. | 2015 Feb 26 |
2 |
| 2 |
24075869 | Disruption of helix-capping residues 671 and 674 reveals a role in HIV-1 entry for a specialized hinge segment of the membrane proximal external region of gp41. | 2014 Mar 6 |
2 |
| 3 |
25756667 | Ibalizumab-human CD4 receptor interaction: computational alanine scanning molecular dynamics studies. | 2014 |
1 |
| 4 |
23066870 | Optimization of CD4/gp120 inhibitors by thermodynamic-guided alanine-scanning mutagenesis. | 2013 Jan |
1 |
| 5 |
20401525 | Naturally occurring IgM anti-leukocyte autoantibodies inhibit T-cell activation and chemotaxis. | 2010 May |
1 |
| 6 |
18209074 | Inhibition of HIV-1 infectivity through an innate mechanism involving naturally occurring IgM anti-leukocyte autoantibodies. | 2008 Feb 1 |
1 |
| 7 |
18632859 | The transmembrane domain of the severe acute respiratory syndrome coronavirus ORF7b protein is necessary and sufficient for its retention in the Golgi complex. | 2008 Oct |
1 |
| 8 |
18981164 | Multiple glycines in TCR alpha-chains determine clonally diverse nature of human T cell memory to influenza A virus. | 2008 Nov 15 |
2 |
| 9 |
15823605 | Vpu-mediated CD4 down-regulation and degradation is conserved among highly divergent SIV(cpz) strains. | 2005 Apr 25 |
1 |
| 10 |
14570906 | CD4 receptor localized to non-raft membrane microdomains supports HIV-1 entry. Identification of a novel raft localization marker in CD4. | 2004 Jan 2 |
1 |
| 11 |
14769016 | Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope. | 2004 Feb 17 |
1 |
| 12 |
15308718 | Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody. | 2004 Sep |
2 |
| 13 |
10820003 | Mapping the CD4 binding domain of gp17, a glycoprotein secreted from seminal vesicles and breast carcinomas. | 2000 May 9 |
1 |
| 14 |
9973399 | Profound enhancement of T cell activation mediated by the interaction between the TCR and the D3 domain of CD4. | 1999 Feb 1 |
1 |
| 15 |
9446793 | Binding of single substituted promiscuous and designer peptides to purified DRB1*0101. | 1998 Jan 14 |
1 |
| 16 |
9707171 | Synthetic peptides representing discontinuous CD4 binding epitopes of HIV-1 gp120 that induce T cell apoptosis and block cell death induced by gp120. | 1998 Aug |
1 |
| 17 |
8554907 | Alanine substitution of two arginines in amino terminus of V3 of SIV disrupts CD4 binding whereas a similar replacement of two amino acids, lysine and arginine, in the carboxyl half of V3 prevents binding of a neutralizing monoclonal antibody. | 1995 Sep |
1 |
| 18 |
8356803 | An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site. | 1993 Sep |
1 |
| 19 |
1713692 | Mutations in the D strand of the human CD4 V1 domain affect CD4 interactions with the human immunodeficiency virus envelope glycoprotein gp120 and HLA class II antigens similarly. | 1991 Aug 1 |
1 |